Đăng xuất
Pregnancy: Laboratory animal studies have not highlighted any teratogenic effects. In the absence of teratogenic effects in animals, no deformities are anticipated in humans. In fact, to date, substances causing malformations in humans have proved teratogenic in animals during studies performed on both species.
There are no relevant or adequate data available at the present time to assess whether betahistine causes deformities or is foetotoxic when administered during pregnancy.
Consequently, betahistine should not be administered during pregnancy as a precautionary measure.
Lactation: There are no data to confirm whether or not betahistine passes into breast milk. The risk is unknown. Therefore, lactation should not be carried out during the administration of betahistine.
